Monoclonal Rat anti‑Mouse IL3 Antibody (clone MP2‑8F8, IF) LS‑C149563
Monoclonal Rat anti‑Mouse IL3 Antibody (clone MP2‑8F8, IF) LS‑C149563
Note: This antibody replaces LS-C7832
Antibody:
IL3 Rat anti-Mouse Monoclonal (MP2-8F8) Antibody
Application:
IF, Flo, SwELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
IL3 Rat anti-Mouse Monoclonal (MP2-8F8) Antibody
Application:
IF, Flo, SwELISA
Format:
Unconjugated, Unmodified
Specifications
Description
IL3 antibody LS-C149563 is an unconjugated rat monoclonal antibody to mouse IL3. Validated for Flow, IF and SwELISA.
Target
Mouse IL3
Synonyms
IL3 | Hematopoietic growth factor | IL-3 | Mast-cell growth factor | MULTI-CSF | P-cell-stimulating factor | Interleukin-3 | Mast cell growth factor | MCGF | P-cell stimulating factor
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Clonality
IgG1,k
Monoclonal
Conjugations
Unconjugated
Immunogen
COS-expressed recombinant mouse IL-3.
Applications
- Immunofluorescence
- Flow Cytometry
- Sandwich ELISA
Usage
Purified antibody should be paired with biotinylated MP2-43D11 antibody as the detection antibody in sandwich ELISA, with purified recombinant mouse IL-3 as the standard.
Presentation
Borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added.
Storage
Store at 2°C to 8°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Immunofluorescence, Flow Cytometry, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Immunoprecipitation, ELISA, Neutralization
Species:
Human, Mouse, Rat
Applications:
IHC - Paraffin, Western blot
Species:
Mouse
Applications:
Western blot, ELISA
Reactivity:
Mouse
Range:
15.6-1000 pg/ml
Reactivity:
Rat
Range:
15.63-1000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/28/2024